.png){kind=icon}
.png){kind=icon}
Return
Serum IL-13 and IL-31 Levels are not Attenuated upon Dupilumab Treatment: Lessons from a Prospective Cohort
.png){kind=icon}
OA
AI
G
I
D
O
E
DOI：10.2340/actadv.v106.adv-2025-0147.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
A
IF:
3.7
Papers:
5.4K
Citations:
8.6K
Organization
Cited Papers